Article
31 Mar 2026
PMPRB Consults On Proposed Practice Directions For PMPRB Hearings
AUTHORS CONTENT
Article
31 Mar 2026
Le CEPMB lance une consultation concernant le projet de directives relatives à la pratique pour ses audiences
Article
03 Dec 2025
L'Ontario propose des mesures législatives pour encadrer les réseaux de fournisseurs privilégiés
Article
03 Dec 2025
Ontario proposes legislation to regulate preferred provider networks
Article
19 Nov 2025
Un programme pilote de l'Ontario ainsi qu'une nouvelle voie de négociation de l'APP pour accélérer l'accès à des traitements novateurs contre le cancer
Article
13 Nov 2025
Publication de la version définitive des Lignes directrices du CEPMB
Article
31 Oct 2025
Ontario Pilot Program And PCPA New Negotiation Pathway Aim To Expedite Access To Breakthrough Cancer Treatments
Article
09 Jul 2025
Finalized PMPRB Guidelines Published
Article
04 Feb 2025
New PMPRB Draft Guidelines Outline Administrative Process For Excessive Price Hearing Recommendations
Article
01 Nov 2024
Evolving Pharmacy Landscape Signals More Stringent Regulatory Scrutiny Of "Patient Steering"
Article
02 Sep 2024
Boehringer Ingelheim Succeeds In Nintedanib PMNOC Action Against JAMP
Article
31 Jul 2024
Discussion Guide For PMPRB Phase 2 Consultations On New Guidelines Outlines Proposed New Framework For Patented Medicine Price Review
Article
06 May 2024
Celebrating World IP Day 2024
Article
02 Apr 2024
Generic Submissions Under Review List Will Identify Generic Filers
Article
03 Mar 2023
Federal Court Dismisses Takeda's Motion To Consolidate Two Dexlansoprazole PMNOC Actions Against Apotex
Article
26 Jan 2023
Federal Court Of Appeal Restores Minister Of Health's Decision To Grant RUZURGI NOC Despite FIRDAPSE Data Protection
Article
22 Nov 2022
Federal Court Of Appeal Upholds Obviousness Finding Re: Janssen's Abiraterone Acetate And Prednisone Combination Therapy Patent
Article
27 Sep 2022
Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Extension Of 24-month Stay
Article
28 Jun 2022
Federal Court Finds Janssen's Macitentan Combination Therapy Patent Valid
Article
31 May 2022
Competition Bureau Resolves Misleading Performance Claims Case